Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2008
03/26/2008EP0871482B1 Recombinant vesiculoviruses and their uses
03/26/2008EP0672147B1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria
03/26/2008CN101151272A Recombinant icosahedral virus like particle production in pseudomonads
03/26/2008CN101151035A Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease
03/26/2008CN101149379A 硅烷混合物 Silane mixture
03/26/2008CN101148667A Preparation and use for affinity human albumin nucleic acid aptamer
03/26/2008CN101148666A Nucleic acid aptamer with high specificity and high affinity to human breast carcinoma tissue, preparation method and application thereof
03/26/2008CN101148467A Oligonucleotide and use thereof for treating lung cancer
03/26/2008CN101148466A RNA disturbance target point for inhibiting MDV proliferating and application thereof
03/26/2008CN101147807A Substances for preventing and treating autoimmune diseases
03/26/2008CN100376687C Genomic markers of hepatitis b virus associated with hepatocellular carcinoma
03/26/2008CN100376594C Double-chain RNA and method for initiate, enhance or adjust immunomodulatory of immune response
03/25/2008US7349811 Designing primers which target and clone preferential gene sequences
03/25/2008US7348471 Expression vector comprising gluten regulatory control sequences for use as tool to enhance heterologous gene expression in plants; tissue engineering
03/25/2008US7348469 Plant farnesyltransferases
03/25/2008US7348422 Fused protein, gene therefor, recombinant vector, recombinant virus, and its use
03/25/2008US7348421 Methods for production of p-hydroxybenzoate in bacteria
03/25/2008US7348420 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
03/25/2008US7348419 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications
03/25/2008US7348418 Comprises nucleotide sequences coding oncogenic polypeptides for diagnosis, detection and treatment of cancer
03/25/2008US7348414 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
03/25/2008US7348410 Flea head, nerve cord, hindgut and malpighian tubule proteins
03/25/2008US7348409 Antimicrobially active peptide
03/25/2008US7348407 Stress-responsive activator of p300 (strap) protein
03/25/2008US7348391 solid support media for use in oligomer synthesis, methods of producing the media, and methods of using the media. In some embodiments, the processes of the invention comprise (a) providing an organic phase comprising an olefin monomer, a cross-linker, a functionalizing reagent and an initiator;
03/25/2008US7348314 Double-stranded ribonucleic acid
03/25/2008US7348172 DNA constructs for obtaining in a filamentous fungus host (actinomycete) a higher production level of a carbohydrate degrading (CD) enzyme, having in its original state a catalytic module (CAT) and a carbohydrate binding module (CBM) separated by a linker region; Xylanase; use in paper industry
03/25/2008US7348171 N-acetylglucosaminyltransferase Vb coding sequences, recombinant cells and methods
03/25/2008US7348170 proteins comprising amino acid sequences and having oxidoreductase activity, coded by DNA sequences exogenously introduced into filamentous fungi; genetic vectors
03/25/2008US7348165 Methods for detecting cancer cells by using nucleic acid encoding for IGF-1 receptor interacting proteins
03/25/2008US7348163 screening compounds for modulation of gamma -aminobutyric acid (GABA-B subtype) receptor transcription; comprises firefly luciferase as reporter gene
03/25/2008US7348162 Nucleotide sequences coding polypeptides for use in the treatment and prevention of hematopoietic disorders, osteoporosis, osteogenesis, paget's disease, periodontal disease, hypercalcemia, cancer, cachexia, and
03/25/2008US7348156 7B2 knockout transgenic animals as models of endocrine disease
03/25/2008US7348154 fusion proteins comprising insulin-like growth factor binding protein-3 fragments of human native-sequence, linked to a synthetic polypetide, used in cell-based assays, as IGF antagonists, in mapping IGF binding sites on wild-type IGFBP-3 and IGF agonist peptides; KIRA phosphorylation
03/25/2008US7348149 Methods of diagnosing Parkinson's disease by measuring expression level of RNA encoding human protein HLLRCR-1
03/25/2008US7348148 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy
03/25/2008US7348146 Single nucleotide polymorphism analysis of highly polymorphic target sequences
03/25/2008US7348145 Multiplex polymerase chain reaction assays using consensus primers to amplify conserved regions of the DNA; hybridizing products onto substrate; chemiluminescence
03/25/2008US7348142 By identifying differential modulation in a combination of genes selected from two groups
03/25/2008US7348141 For single nucleotide polymorphisms (SNPs) using fluorescently labelled oligonucleotide probes; solid phase synthesis
03/25/2008US7348007 Mage C2 antigenic peptides and uses thereof
03/25/2008US7348006 histidine to improve pH stability, adjuvant adsorption, and reduce antigen hydrolysis in vaccines using aluminum salt(s)
03/25/2008US7348004 Immunoglobulin chimeric monomer-dimer hybrids
03/25/2008US7348003 Tumor necrosis factor (TNF)-related apoptosis-inducing ligands; anticarcinogenic and antiproliferative agents; graft versus host disease, AIDS, neurodegenerative disorders
03/25/2008CA2243578C High affinity nucleic acid ligands of complement system proteins
03/25/2008CA2203652C A method of down-regulating gene expression
03/25/2008CA2189984C P75 tnf receptor promoters
03/25/2008CA2173319C Radiation sensitization using texaphyrins
03/25/2008CA2073500C Compositions and methods for detecting and modulating rna activity and gene expression
03/20/2008WO2008033375A2 Long lasting drug formulations
03/20/2008WO2008033374A2 Ocl-2a3 compositions and uses thereof
03/20/2008WO2008031226A1 Mammalian oocyte development competency granulosa markers and uses thereof
03/20/2008WO2008016909A3 Nucleotide analogs
03/20/2008WO2007104318A3 Oligonucleotides comprising signalling pairs and hydrophobic nucleotides, stemless beacons, for detection of nucleic acids, methylation status and mutants of nucleic acids
03/20/2008WO2004111075A3 Alternative reading frame polypeptides for treatment
03/20/2008WO2001025398A3 Process for inducing functional tolerance to gene transfer products
03/20/2008US20080072354 Nucleic acid molecules and other molecules associated with plants
03/20/2008US20080072352 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same
03/20/2008US20080072349 Rubisco Activase with Increased Thermostability and Methods of Use Thereof
03/20/2008US20080072348 Nucleic acid molecules and other molecules associated with plants
03/20/2008US20080072347 Transcription factor stress-related proteins and methods of use in plants
03/20/2008US20080072340 Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics
03/20/2008US20080072339 Double flower Calibrachoa breeding methods and plants produced therefrom
03/20/2008US20080071075 siRNA targeting proteasome 26S subunit, non-ATPase, 10 (Gankyrin or PSMD10)
03/20/2008US20080071074 Compositions, probes, and conjugates and uses thereof
03/20/2008US20080071073 siRNA targeting ubiquitin ligases
03/20/2008US20080071072 Aqueous solution containing cationic stabilizer; plasmids; genomes; kits
03/20/2008US20080071071 Substrate comprises nucleic acid encoding hybrid amino acid sequence test sequence and affinity tag, and binding agent that recognizes affinity tag; contacting substrate with translation effector to translate hybrid
03/20/2008US20080071070 Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides
03/20/2008US20080071069 For delivering DNA/RNA into cells
03/20/2008US20080071068 Cytoplasmic Localization Dna and Rna
03/20/2008US20080070996 Transfers a D-glucuronic acid residue to an N-acetyl-D-galactosamine residue when the N-acetyl-D-galactosamine residue is present at the non-reducing end of the chondroitin backbone, or transfers an N-acetyl-D-galactosamine residue to a D-glucuronic acid residue
03/20/2008US20080070857 Comprises a substance that inhibits expression of macrophage migration inhibitory factor (MIF) such as siRNA of MIF; adenocarcinoma or colon cancer
03/20/2008US20080070840 Polypeptides or peptides modified to include at least one antibody Fc region and, optionally, one or more water soluble polymers; have ability to stimulate in vivo and in vitro production of platelets, and/or megakaryocytopoietic activity, i.e., the ability to stimulate production of platelet precursors
03/20/2008US20080070836 Zinc transporter LIV1 can be used as an epithelial-mesenchymal transition (EMT) regulatory agent; further, because EMT is involved in cancer progression, LIV1 antisense nucleotides and the like may be used as pharmaceuticals for treating cancer
03/20/2008US20080070835 Hla-Dr-Binding Antigen Peptide Derived From Wt1
03/20/2008US20080070831 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications
03/20/2008US20080070829 Family of pesticidal proteins and methods for their use
03/20/2008US20080070798 Nucleotide sequencing via repetitive single molecule hybridization
03/20/2008US20080070795 Linker compound, probe, and probe-immobilized carrier
03/20/2008US20080070305 Inhibition of expression of a target gene
03/20/2008US20080070298 Promoter of Synoviolin Gene
03/20/2008US20080070291 Nucleotide sequences coding chlorophyllase for use in preparation of paper products, detergents and foods
03/20/2008US20080070286 Dna Participating in Hydroxylation of Macrolide Compound
03/20/2008US20080070278 Immunoglobulin fusion comprising clostridial light chain for use in controlling interaction of particular cell types with their external environment; drug targeting and delivery
03/20/2008US20080070274 Bipolymer microarray for separating, purifying, concentrating and/or immobilizing compounds in a three dimensional conformation
03/20/2008US20080070268 Differential expression profiling analysis of cell culture phenotypes and the uses thereof
03/20/2008US20080070260 Canola event PV-BNGT04(RT73) and compositions and methods for detection thereof
03/20/2008US20080070258 Polyamide nucleic acid derivatives and agents, and processes for preparing them
03/20/2008US20080070252 CHR and POMC effects on animal growth
03/20/2008US20080070251 Method of Producing Factor VIII Proteins by Recombinant Methods
03/20/2008US20080070249 Peroxisome proliferator activator gamma coactivator-1 alpha (PGC-1 alpha ) for use as modulator of glucose transport; antidiabetic agents
03/20/2008US20080070247 Physiogenomic method for predicting effects of exercise
03/20/2008US20080070246 Recombinant protein and method of screening for agents that modulate polypeptide aggregation
03/20/2008US20080070241 Kits for amplifying and detecting nucleic acid sequences
03/20/2008US20080070240 Composition for deaminating dna and method of detecting methylated dna
03/20/2008US20080070232 Expression Vectors Containing a Truncated Epstein Barr Nuclear Antigen 1 Lacking the Gly-Gly-Ala Domain for Enhanced Transient Gene Expression
03/20/2008US20080069846 Gene coding, gene expression, purification; used as detergents, cosmetics, leather processing, softening for food, meats, animal feeds
03/20/2008US20080069839 Isolation and characterization of the precursor virus of human sars virus: sars-associated corona virus-like virus
03/20/2008US20080069830 Isolation Dna; nucleotide sequences; genetic engineering